The Sunday Times is reporting the executives from Astrazeneca are holding ‘secret’ talks to acquire MDVN, who just rebuffed an ‘inadequate’ bid from Sanofi. I never quite understood how these rumors get leaked. Perhaps one of the idiot secretaries, or receptionist, at AZN sold the info for 10 bucks to the Sunday Times, effectively costing her company millions in potential expenditures for making an elevated bid for MDVN?
Either way, this so called bid has not been proposed to the lads at Medivation just yet.
In March, MDVN hired JP Morgan to explore ‘strategic alternatives.’
If you enjoy the content at iBankCoin, please follow us on Twitter
Lol, idiot secretaries. They are selling half on the double and letting the rest ride.
Maybe no intention by AZN to offer anything, but AZN floated rumor to screw sanofi? LOL
In case anyone is interested this provides information on clinical phase trial research, i.e./e.g. $MDVN .
https://www.nlm.nih.gov/services/ctphases.html